Activist-Investor Carl Icahn Sues Illumina Board for Violating ‘Fiduciary Duties’

Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina and accused them of breaching their fiduciary duties, according to a sealed copy of the complaint on Tuesday.

The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail.

Illumina said it is reviewing the complaint, while Icahn and Grail did not immediately respond to Reuters requests for a comment.

Read the source article at Yahoo Finance